changes in cytosolic free calcium concentration in isolated rat parotid cells by cholinergic and...
TRANSCRIPT
Vol. 131, No. 3, 1985
September 30, 1985
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Pages 1048-1055
CHANGES IN CYTOSOLIC FREE CALCIUM CONCENTRATION IN ISOLATED RAT PAROTID CELLS BY CHOLINERGIC AND B-ADRENERGIC AGONISTS
Haruo Takemura
Department of Pharmacology, Sapporo Medical College, Sapporo 060, Japan
Received July 29, 1985
The alteration in the concentration of cytosolic free calcium ([Ca2+]i ) in isolated rat parotid cells caused by autonomic agents was directly measured using the Ca-sensitive fluorescent probe, quin2. [Ca2+Ii of unstimulated cells was estimated to be 162.7i3.2 nM in normal medium. Carbachol (CCh) and iso- proterenol (ISP) caused a rapid rise in [Ca2+]i in a dose-dependent manner. Maximum increases in [Ca2']i induced by CCh and ISP were approximately 100%
respectively. ~~~1:'" r~~i~'":~~~ 1~~e~~a2t]i,
In Ca-free medium, CCh produced a
resti;g level within 3-4 min, followed by a slow decay and a return to
[Ca2+li. while all doses of ISP tested failed to change
These results suggest that CCh mobilizes Ca2+ from both extracel- lular and intracellular pools and then results in a rise in [Ca2']i, whereas ISP may slightly mobilize only the extracellular Ca pool. @ 1985 Academic Press, Inc.
A rise in [Ca 2+ Ii is believed to play a key role in the regulation of
amylase release induced by autonomic agents from parotid gland cells (172).
This assumption is based on the indirect evidence reported below (3-9).
First, CCh, a cholinergic agonist, induces amylase release, which is dependent
on extracellular Ca2+ and accompanied by an increased influx of 45Ca2+ into
parotid cells. Second, amylase release stimulated by ISP, a 8-adrenergic
agonist, is inhibited in cells depleted of Ca but not by short-term exposure
to Ca-free medium, although ISP activates the accumulation of cyclic AMP.
Moreover, ISP stimulates 45Ca2+ influx as well as 45Ca2+ efflux. In addition
to these facts, previous studies showed that ISP-induced amylase release is
potentiated by a low dose of CCh (10) but inhibited by high doses of CCh (11).
These stimulatory and inhibitory effects are thought to be dependent on the
elevation of [Ca 2+ 1 i but independent of the accumulation of cyclic AMP.
Abbreviations: BSA, bovine serum albumin; [Ca 2+]i, concentration of cytosolic free calcium; CCh, carbachol; DMSO, dimethyl sulfoxide; EGTA, ethylene bis-(B- aminoethylether)-N,N,N',N'-tetraacetic acid; ISP, (-)-isoproterenol (+)-bi- tartrate
0006-291X/85 $1.50 Copyright 0 I985 by Academic Press, Inc. All rights of reproduction in any form reserved. 1048
Vol. 131, No. 3, 1985 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Despite these facts, no direct measurement of [Ca2+li in parotid cells has yet
been made. The present study was undertaken to measure directly [Ca2t]i using
a Ca selective fluorescent indicator, quin2 (12) and to further investi-
gate the role of [Ca2+li in amylase release.
MATERIALS AND METHODS
KumamZZn2 acetoxymethyl ester (quin2/AM) was obtained from Dojin Chemicals,
BoehringLr; Japan; A23187 from Calbiochem-Behring; BSA (fraction V) from
atropine sulfate from Merck; and CCh, ISP and DL-propranolol HCl from Sigma. Quin2/AM and A23187 were dissolved in DMSO as stock solutions at concentrations of 50mM and lOmM, respectively. The final concentration of DMSO in the incubation medium was 0.1% (V/V),
Isolated parotid cells were prepared from 3 male Wistar rats (220-3003) as described previously (13). The parotid cells obtained were suspended in modified Krebs-Ringer-Hepes (KRH) medium of the following composition (mM) containing 2% BSA: NaCl, 120; KCl, 5.0; CaCl2, 2.0; MgC12, 1.0; Na pyruvate, 5.0; Na glutamate, 5.0; Na fumarate, 2.5; Na S-hydroxybutyrate, 5.0; Hepes, 10.0, 1x107
buffered with KOH to pH 7.4. The cell suspension, containing about cells/ml, was incubated with 50 uM quin2/AM for 45 min at 37'C and
gassed continuously with 02. The cells were then washed twice by centrifuga- tion (50xg,for 3 min) with KRH medium containing 0.2% BSA and maintained at room temperature. Before use, the cell suspension was centrifuged and the cells were resuspended in fresh normal KRH medium or Ca-free KRH medium with 0.1 mM EGTA added, 1-2 x10' cells/ml.
both of which contained 0.2% BSA, at cell concentration of Fluorescence was measured at 37'C in a Hitachi 650-10s
spectrofluorometer equipped with a thermostatically controlled heat exchanger and a magnetic stirrer. The excitation and emission wavelengths were 339nm (5nm slits) and 492nm (10nm slits), respectively. At the end of the analysis, 0.06% Triton X-100 was added to measyy the maximum fluorescence (Fmax) in the presence of an excess amount of Ca (> 1mM) and the minimum fluorescence (Fmin) was measured with 0.5 mM MnC12 (14). Fmax, Fmin and the fluorescence of intracellular quin2 were corrected for changes in cell autofluorescence and for leakage of quin2 in extracellular medium by using 0.1 mM MnC12 (14). A23187 (0.1 uM) did not affect cell autofluorescence and the interference of 0.1 PM A23187 with Fmax was less than 5%. [Ca*+]i was calculated assuming a quin22Ca dissociation constant of 115nM as described by Tsien et al. (12).
The values of the data were given as the mean istandard error. The comparative significance of the values was examined by paired t-test.
RESULTS
The [Ca2+li of unstimulated rat parotid cells in normal medium was calcu-
lated from the fluorescence of quin2 to be 162.7 t 3.2 nM (n=36). The addition
of CCh to the cell suspension caused a rapid increase in [Ca *+I, in a dose-
dependent manner in the range of 0.1 to 100 UM (Fig.1, Table 1). [Ca2+ 1 1
elevated by higher doses of CCh (10, 100 uM) decreased slightly and gradually
for a few min and then maintained its higher level, at least within the
observed time (10 min). Atropine (10 UM) abolished the elevation of [Ca *+li
1049
Vol. 131, No. 3, 1985 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
O.lyM CCh
1pM ISP
3 350- 1OpM Atropine
5 250- .- 200-
-MM I
‘“‘f
200-
T 150-
.u 150- b&ftJw
10~M CCh 2 min t
100pM CCh
Figure 1. Effects of various doses of CCh and the combination with 1 uM ISP on the quin2 fluorescence in isolated rat parotid cells. Quin2 was loaded as described in METHODS. CCh, ISP and atropine were added at the times indicated by arrows. Calculated Ca2+ (nM) is indicated at the left of each trace.
stimulated by CCh. The maximum rise in [Ca2’li occured at 10 $I CCh and was
about 2 times higher than the unstimulated level.
Table 1. The effect of carbachol and isoproterenol on cytosolic free Ca” in isolated rat parotid cells in normal and Ca-free media
% increase of untreated cell level
Additions Concentration Normal medium Ca-free (0.1 mM CUM) EGTA) medium
: “ , ”
Carbachol 0.1 21.4 ? 4.4 (9) >‘- ;g
1 56.5 t 10.6 (5) :“:”
10 101.4 + 13.8 (9) :% ::
100 94.7 * 10.3 (5)
Isoproterenol 0.1 0.1 2 3.0 (3)
1 5.3 f 2.0' (6)
10 13.3 f 3.3* (4) *:s
100 25.4 + 4.8 (6)
1.4 + 1.4 (3)
9;9 + 3.4* (3) >p :s
13.3 ? 0.4 (3)
*:x 19.9 t2.0 (4)
0 (1)
-2.2 (2)
1.2 (2)
1.2 to.7 (4)
Quin2 was loaded as described in METHODS. The values were expressed as % increase in 1Ca2+Ii after the addition of drugs compared with unstimulated levels. Unstimulated levels of [Ca2+]i in normal medium and in Ca-free medium were 162.7t3.2 nM and 86.8t2.3 nM, respectively. The number of experi- ments is shown in parentheses. “P<O.O5, “;“P < 0.01 vs. unstimulated level.
1050
Vol. 131, No. 3, 1985 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
1yM ISP 150- t
10!.1M ISP
IOJJM Propranolol
7 z 250-
-m-*M "Ilj-w#qhlkw x- m 150- 22 t t
100~.1M ISP 2 min lOOtiM ISP
Figure 2. Effects of ISP on the quin2 fluorescence in parotid cells. Quin2 was loaded as described in METHODS. ISP and propranolol were added at the times indicated by arrows. Calculated Ca2+ (nM) is indicated at the left of each trace.
The effect of ISP on [Ca2+li indicated b y quin2 fluorescence is shown in
Fig. 2. Although ISP at concentrations of 1 to 100 PM increased [Ca 2+]i dose-
dependently, the degree of increase in [CaZ+li was small (Table 1). ISP
(1 vM), which induced a distinct release of amylase in previous studies
(lO,ll), caused an increase of only 5.3% over resting [Ca *+li. Propranolol
(10 ~JM) inhibited the stimulatory effect of ISP on [Ca *+li.
Previous reports (10,ll) have shown that CCh has both stimulatory and
inhibitory effects on amylase release but not on the accumulation of cyclic
AMP in the presence of 1 UM ISP. To examine the effect of a combination of
CCh and ISP on [Caz+li, 1 UM ISP was added after the addition of various doses
of CCh (Fig. 1). The elevation of [Ca2+ji stimulated by all doses of CCh
tested was unaffected by the addition of ISP.
To determine whether a rise in [Ca 2+li in the presence of CCh or ISP is
dependent on extracellular Ca 2t , the fluorescence of quin2-loaded cells that
were suspended in Ca-free medium containing 0.1 mM EGTA was examined. The un-
stimulated level of [Ca2+li of parotid cells in Ca-free medium was 86.822.3 nM
(n=15). As shown in Fig. 3, the addition of 100 UM CCh to the cell suspension
rapidly increased[Ca2+li, but [Ca2+ji decayed slowly and returned its starting
value within 3 - 4 min. CCh did not change [Ca2+li in the presence of 10 UM
atropine. The increase in [Ca2+li elevated by CCh was dose-dependent in the
1051
Vol. 131, No. 3, 1985 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
s 5 150-
l@M Atropine lOOtiM CCh
I I 120-
0.1% DMSO O.lpM A23187
O.lyM A23187 2 min 100j~M CCh
Figure 3. Effects of CCh, ISP and A23187 on the quin2 fluorescence in &-free medium containing 0.1 mM EGTA. Quin2 was loaded as described in METHODS. CCh, atropine, ISP, 0.1% DMSO and A23187 were added at the times indicated by arrows. Calculated Ca*+ (nM) is indicated at the left of each trace.
range of 1 to 100 IJM but was only about 20% of the unstimulated level even at
the highest dose (Table 1). On the other hand, 100 nM ISP failed to
increase [Ca 2+ Ii in Ca-free medium, and a transient rise in [Ca 2+li caused by
the subsequent addition of CCh was similar to that in the presence of CCh
alone. Lower doses of ISP (5 10 uM) did not change [Ca2+li (Table 1).
Because of absence of extracellular Ca 2t , CCh-stimulated elevation of
[Ca2+ Ii is ascribed to the release of Ca 2+ from an intracellular Ca store.
To determine the location of this CCh-sensitive store, the alteration in
[Ca2+l 1 caused by CCh in Ca-free medium was compared with that produced by
A23187. A23187 (0.1 uM) increased [Ca2+li more slowly than did CCh, followed
by a slow decay to a new steady value higher than that of untreated cells
(Fig. 3). After [Ca2+ Ii elevated by 100 uM CCh returned to the unstimulated
value, the addition of A23187 to the cell suspension produced a comparative
increase in [Ca2+li in the p resence of A23187 alone.
DISCUSSION
The [Ca2+li of unstimulated rat parotid cells in normal medium containing
2 mM Ca2+ was about 160 nM. This value is very close to that reported for
1052
Vol. 131, No. 3, 1985 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
[ ca2+ ] which was measured using quin2 in exocrine pancreatic acini (15,16). 1
On the other hand, the removal of Ca 2t from suspension medium and the addition
of 0.1 mM EGTA led to a value which was half that of [Ca 2+ Ii in normal medium.
Previous investigations (10,ll) showed that CCh induces amylase release
in the range of 0.1 to 100 UM and the maximum release, which is about two
times that of control, occurs at a concentration of 10 IJM. This dose-depend-
ent relationship corresponded to that of [Ca2'li response to this agonist
(Fig. 1, Table 1). However, all doses of CCh failed to stimulate amylase
release in Ca-free medium (lO,ll), although CCh caused a transient and slight
increase in [CaZtli (Fig. 3). In the absence of extracellular Ca2+, CCh
stimulated the increase in [Ca ?+li in pancreatic acini (15) more than in
parotid cells (Table 1) and was still able to elicit amylase release in the
former (17). Therefore, the elevation (>160 nM) of [Ca2+li above resting
level in the presence of extracellular Ca 2t is presumed to result in the
induction of amylase release from parotid cells. A transient rise in [CaZtli
stimulated by CCh in Ca-free medium seems to be associated with the early
phase of potassium movement (2) rather than amylase release. Such a CCh-
sensitive Ca pool is thought to possibly be located in plasma membrane. This
supposition is based on the following observations. First, A23187, which
releases Ca2+ from liver mitochondria (18) and from pancreatic microsomes
(19), increased [Ca2'li more slowly than did CCh, and was then followed by a
slow decay to a new steady level. A similar increase in (Ca2t]i, even after
the addition of CCh, also occured (Fig. 3). Second, it is suggested that
methacholine, a cholinergic agonist, provokes a breakdown of phosphatidyl-
inositol 4,5-bisphosphate which is involved in Ca 2t release from the plasma
membrane in parotid acinar cells (20). In addition, inositol 1,4,5-trisphos-
phate, which is a product of this breakdown, releases Ca 2+ from platelet
membranes (21). Third, there is evidence from studies of 45 Ca fluxes showing
that a CCh-sensitive Ca pool is located in or near the plasma membrane (22).
Thus, it seems likely that CCh releases Ca 2t from an intracellular store
(presumably plasma membrane), accompanying a continuous increase in Ca 2t entry
1053
Vol. 131, No. 3, 1985 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
from the extracellular pool, and then results in a rise in [Ca*+] i, which
induces amylase release.
Studies of 45Ca2+ efflux support the hypothesis that 8-adrenergic
agonists utilize intracellular pool(s) of Ca 2+ to promote amylase release (2).
However, the present observations showed that ISP failed to elevate [Ca 2t Ii in
Ca-free medium, despite the fact that ISP increased [Ca *+li slightly, being
dependent on extracellular Ca 2+ . The discrepancy between the increase in 45Ca
efflux and no change of [Ca*+]. 1 may be explained as follows. Wallach and
Schramm (23) have reported that the secretary granules have the highest Ca
content among the subcellular fractions and most of the Ca is secreted con-
comitantly with the exportable protein. The amount of amylase release induced
by 1 uM ISP in Ca-free medium was similar to that in normal medium (10,ll).
It is, therefore, probable that amylase and 45ca2t are released by exocytosis
without altering [Ca2+li, and that the contribution of Ca2+ to ISP-induced
amylase release is small.
Both stimulatory and inhibitory effects of CCh on 1 uM ISP-induced
amylase release have been supposed to be ascribed to the degree of elevation
of Ca*+ rather than that of cyclic AMP accumulation (10,ll). The direct
2+ measurement of [Ca Ii using quin2 seems to confirm this supposition. Since
ISP did not modify ICaztli in the presence of CCh, it appears that [Ca*'l 1
might regulate amylase release induced by cyclic AMP as suggested by Butcher
and Putney (2). The inhibition of ISP-induced amylase release occurred at
concentrations above 1 I-IM CCh (11). Therefore, the increase of more than 50%
in [Ca 2t 1, may possibly bring about the inhibition of amylase release induced
by ISP. In addition, it provides further support for the previous assumption
that a small alteration in [Ca2+li subtly regulates amylase release when the
accumulation of cyclic AMP is not modified (13).
ACKNOWLEDGMENT : The author wishes to thank Professor H. Ohshika for advice and encouragement.
1054
Vol. 131, No. 3, 1985 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
REFERENCES
1. Butcher, F.R. (1978) Adv. Cyclic Nucleotide Res. 9, 707-721. 2. Butcher, F.R. and Putney, J.W., Jr. (1980) Adv. Cyclic Nucleotide Res. 13,
215-249. 3. Kanagasuntheram, P. and Randle, P.J. (1976) Biochem. J. 160, 547-564. 4. Leslie, B.A., Putney, J.W., Jr., and Sherman, J.M. (1976) J. Physiol. 260,
351-370. 5. Putney, J.W., Jr. (1976) J. Phamarcol. Exp. Ther. 199, 526-537. 6. Miller, B.E. and Nelson, D.L. (1977) J. Biol. Chem. 252, 3629-3636. 7. Putney, J.W., Jr., Weiss, S.J., Leslie, B.A. and Marrier, S.H. (1977) J.
Pharmacol. Exp. Ther. 203, 144-155. 8. Putney, J.W., Jr., Van De Walle, C.M. and Leslie, B.A. (1978) Mol.
Pharmacol. 14, 1046-1053. 9. Butcher, F.R. (1980) Biochim. Biophys. Acta 630, 254-260.
10. Takemura, H. (1984) Japan. J. Pharmacol. 36, 107-109. 11. Takemura, H. (1984) Japan. J. Pharmacol. 35, 9-17. 12. Tsien, R.Y., Pozzan, T. and Rink, T.J. (1982) J. Cell Biol. 94, 325-334. 13. Takemura, H. and Ohshika, H. (1985) J. Dent. Res. In press. 14. Hesketh, T.R., Smith, G.A., Moore, J.P., Taylor, M.V. and Metcalfe, J.C.
(1983) J. Biol. Chem. 258, 4876-4882. 15. Ochs, D.L., Korenbrot, J.I. and Williams, J.A. (1983) Biochem. Biophys.
Res. Comm. 117, 122-128. 16. Powers, R.E., Johnson, P.C., Houlihan, M.J., Saluja, A.K. and Steer,
M.L. (1985) Am. J. Physiol. 248, C535-C541. 17. Gardner, J.D., Costenbader, C.L. and Uhlemann, E.R. (1979) Am. J.
Physiol. 236, E745-E762. 18. Reed, P.W. and Lardy, H.A. (1972) J. Biol. Chem. 247, 6970-6977. 19. Wakasugi, H., Kimura, T., Haase, W., Kribben, A., Kaufmann, P. and Schulz,
I. (1982) J. Membrane Biol. 65, 205-220. 20. Weiss, S.J., McKinney, J.S. and Putney, J.W., Jr. (1982) Biochem. J. 206,
555-560. 21. Adunyah, S.E. and Dean, W.L. (1985) Biochem. Biophys. Res. Comm. 128,
1274-1280. 22. Poggioli, J. and Putney, J.W., Jr, (1982) Pflugers Arch. 392, 239-243. 23. Wallach, D. and Schramm, M. (1971) Eur. J. Biochem. 21, 433-437.
1055